MHUA (MeihuaMed) Market Value to Book Value Ratio

Meihua Medical Technologies Co., Ltd. (MHUA) - corporate logo

MeihuaMed (MHUA) focuses on upgrading compositions and optimizing costs when creating basic medical devices. Global sales reach is limited by geopolitical tensions and the risks of electronics supply chain disruptions from Asia. This price chart on GURU.Markets, where the indicator stands at 1.46, confirms the impact of stable demand for disposable consumables, despite low product profitability in the PRC.

MHUA - meihuamed.com Market-to-Book Ratio over the range 04/28/2023 - 12/13/2025

MHUA (MeihuaMed): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price meihuamed.com|MHUA - Analyst Consensus Forecast
- market capitalization data:
Market Value Meihua Medical|MHUA - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share MeihuaMed|MHUA - Total Stockholders' Equity|Market Capitalization to Book Value Ratio meihuamed.com|MHUA - Total Business Assets
- debt and liquidity data:
Total Debt to Capital MeihuaMed|MHUA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital meihuamed.com|MHUA - Company Total Debt|Debts to Book Capitalization Meihua Medical|MHUA - Company Long-Term Debts|Company Short-Term Debt MeihuaMed
Initial company analysis:Meihua Medical Technologies - MHUA
Manufactured products of MeihuaMed

To build a resilient portfolio, I utilize this filter to separate intrinsic asset value from market noise. This metric compares the current market value of MeihuaMed (MHUA) to its net assets, revealing the extent of the business's overvaluation. In the case of MeihuaMed (MHUA), this balance is sustained by capital-intensive production and stringent FDA sterility requirements. By analyzing the market value to book value multiple trend, an investor can determine the fair entry point.

Direct competitors

ISRG: Market Capitalization to Book Value Ratio|DHR (danaher.com) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio Utah Medical Products|Market Cap to Book Value Multiple KRMD (korumedical.com)|Market Value to Book Value Ratio Nyxoah|MBOT - Market Value to Book Value|Pro-Dex Corp - Market Cap to Net Assets Ratio|ZTEK: Market Capitalization to Book Value Ratio|ELUT (Elutia Inc.) - Market Value to Book Value Ratio|milestonescientific.com (MLSS) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio NXGL (NEXGEL)|Market-to-Book Ratio RVP|Market Value to Book Value Ratio Harvard Bioscience HBIO|Capitalization to Book Value Ratio Femasys Corporation FEMY|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value